Browsing: Merck

Pharmaceutical giants Moderna and Merck said Wednesday that an experimental vaccine treatment has shown signs of preventing cancer from returning or spreading in a study of high-risk melanoma patients

Moderna and Merck have announced that a personalised mRNA cancer vaccine called Intismeran reduced the risk of recurrence and spread of melanoma in a late-stage trial, a major success in a new field of cancer treatment that sent Moderna’s shares surging as much as 160 percent

Wall Street Horizon head of corporate event research Christine Short and Sherwood News markets editor Luke Kawa chat with Yahoo Finance’s Julie Hyman about Moderna’s (MRNA) and Merck’s (MRK) melanoma vaccine trial success

Lipfendra can be taken in conjunction with or an alternative to statins, the most prescribed medication in the US